• ALK-Abello Phase II allergy data-BioCentury.comThe BioCentury 100;The Clear Route to ROI;Because Real Intelligence is Hard to Find;BCIQ;and BioPharma's Knowledge Center;...

• 爱尔开-阿贝优 产品和联络信息|敏思网页 中国爱尔开-阿贝优 ALK-Abello A/S 爱尔开-阿贝优公司 爱尔开-阿贝优 产品 新闻...

• ALK-Abello to acquire Dutch Allergy Division(Artu ...ALK-Abello A/S(ALK),a Denmark-based pharmaceutical company focused on allergy,has signed a share purchase agreement with Fornix BioSciences N.V.regarding ...

• ALK-ABELLO market valuation multiples(DK0060027142-...market valuation ratio.ALK-ABELLO shows a EV/EBITDA ratio of...ALK-ABELLO included8.42 Sector Pharmaceuticals8.49 S&P 5007.95 ...

• Danish ALK-Abello announces positive Phase III data for ...3 August 2011-Danish immunotherapy company ALK-Abello A/S(CPH:ALK B)announced today data from two Phase III trials with its ragweed allergy ...

• ALK-Abello ser lyst p fremtiden-www.nordvestnyt.dk-...allergiselskabet alk-abello frer an med en vaccine mod allergi overfor grs....s det bliver tilskudsberettiget.Samtidig er man i gang med at lave en ...

• Affitech A/S:CPH:AFFITECH 报价和资讯-Google 财经非上市 TopoTarget A/S非上市 Bavarian Nordic A/S非上市 NeuroSearch A/S非上市 ORIGIO A/S非上市 Genmab A/S非上市 H.Lundbeck A/S非上市 ALK-Abello A/S非上市...

• Affitech A/S:CPH:AFFITECH 报价和资讯-Google 财经TopoTarget A/S非上市 LifeCycle Pharma A/S非上市 NeuroSearch A/S非上市 ORIGIO A/S非上市 Bavarian Nordic A/S非上市 Genmab A/S非上市 ALK-Abello A/S非上市 ...